ImmunityBio, Inc. - stock earnings
IBRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -233.4 million USD | 139000 USD |
| 2023Q3 | -95.6 million USD | 82000 USD |
| 2023Q2 | -137.9 million USD | 41000 USD |
| 2023Q1 | -151.2 million USD | 360000 USD |
| 2022Q4 | -108.3 million USD | 73000 USD |
| 2022Q3 | -110.9 million USD | 118000 USD |
| 2022Q2 | -94.6 million USD | 35000 USD |
| 2022Q1 | -102.8 million USD | 14000 USD |
| 2021Q4 | -91.3 million USD | 390000 USD |
| 2021Q3 | -87.6 million USD | 66000 USD |
| 2021Q2 | -88.3 million USD | 339000 USD |
| 2021Q1 | -79.6 million USD | 139000 USD |
| 2020Q4 | -67.8 million USD | -147000 USD |
| 2020Q3 | -65.6 million USD | 151000 USD |
| 2020Q2 | -51.4 million USD | 436000 USD |
| 2020Q1 | -37.0 million USD | 165000 USD |
| 2019Q4 | -15.6 million USD | 9000 USD |
| 2019Q3 | -15.6 million USD | 12000 USD |
| 2019Q2 | -16.7 million USD | 17000 USD |
| 2019Q1 | -17.9 million USD | 5000 USD |
| 2018Q4 | -17.3 million USD | 7000 USD |
| 2018Q3 | -23.6 million USD | 31000 USD |
| 2018Q2 | -27.7 million USD | 4000 USD |
| 2018Q1 | -27.5 million USD | 5000 USD |
| 2017Q4 | -24.5 million USD | 12000 USD |
| 2017Q3 | -24.0 million USD | 8000 USD |
| 2017Q2 | -23.5 million USD | 14000 USD |
| 2017Q1 | -24.5 million USD | 11000 USD |
| 2016Q4 | -24.2 million USD | 14000 USD |
| 2016Q3 | -31.9 million USD | 12000 USD |
| 2016Q2 | -34.0 million USD | 12000 USD |
| 2016Q1 | -30.7 million USD | 6000 USD |
| 2015Q4 | -76.8 million USD | 14000 USD |
| 2015Q3 | -42.6 million USD | 10000 USD |
| 2015Q2 | -84.6 million USD | 91000 USD |
IBRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -583.2 million USD | 622000 USD |
| 2022 | -417.3 million USD | 240000 USD |
| 2021 | -349.8 million USD | 934000 USD |
| 2020 | -224.2 million USD | 605000 USD |
| 2019 | -160.2 million USD | 2.2 million USD |
| 2018 | -96.2 million USD | 47000 USD |
| 2017 | -96.4 million USD | 45000 USD |
| 2016 | -120.8 million USD | 44000 USD |
| 2015 | -236.9 million USD | 236000 USD |
| 2014 | -6.2 million USD | 641000 USD |
IBRX
Price: $9.15
52 week price:
Earnings Per Share: -1.15 USD
P/E Ratio: -4.40
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.2 million
Market Capitalization: 4.1 billion